ESAM and myeloid sarcoma: They conclude that endothelial cell adhesion molecules, pro-inflammatory cytokines, vascular growth factors and other molecules could contribute to vascular remodeling that is typical of MS, which can be exacerbated during chronic hypoperfusion in later stages of the lesion progression.